TMEM115: a promising marker for glioma immunotherapy and prognosis
BackgroundGlioma is a common malignant primary brain tumor characterized by a highly immunosuppressive tumor microenvironment and unfavorable prognosis. Transmembrane protein 115 (TMEM115) is a protein-coding gene. It may play a role in the retrograde transport of proteins from the Golgi to the endo...
Saved in:
| Main Authors: | Hang Yin, Feng Wang, Haiyan Xu, Manyu Xu, Pengpeng Lu, Xiaojing Zhang, Lei Yang, Bing Lu, Pingping Sun, Jianfei Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1598499/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TMEM150A overexpression was associated with poor prognosis and cancer progression in glioma verified by comprehensive analysis and cell experiments
by: Hao-Qiang Xu, et al.
Published: (2025-07-01) -
TMEM71 is crucial for cell proliferation in lower-grade glioma and is linked to unfavorable prognosis
by: Jiabao Xie, et al.
Published: (2025-03-01) -
RETRACTED: TMEM107 inhibits EMT and invasion of NSCLC through regulating the Hedgehog pathway
by: Huihui Xu, et al.
Published: (2021-01-01) -
Pharmacokinetics of dipeptide anxiolytic GB-115 after oral administration in different animals species and humans
by: S. Yu. Raskin, et al.
Published: (2017-07-01) -
Experimental assessment of ladasten and GB-115 effects on the antinociceptive tolerance to morphine
by: M. A. Konstantinopolsky, et al.
Published: (2016-03-01)